BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
CN Stock MarketDetailed Quotes
603108 Shanghai Runda Medical Technology
- 18.39
- -0.89-4.62%
Not Open May 15 15:00 CST
11.10BMarket Cap-301.48P/E (TTM)
19.27High18.36Low178.76KlotVolume19.27Open19.28Pre Close332.36MTurnover2.96%Turnover Ratio199.89P/E (Static)603.65MShares24.9152wk High2.62P/B11.10BFloat Cap11.7752wk Low21.21Limit Up603.65MShs Float27.60Historical High17.35Limit Down4.72%Amplitude3.92Historical Low0.10Dividend TTM18.59Avg Price92.99KlotAsk0.54%Div YieldTTM100Lot Size80.24KlotBid
Shanghai Runda Medical Technology Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -19.81%1.66B | -9.13%8.31B | -10.36%6.18B | -8.54%4.14B | -4.85%2.07B | -12.84%9.15B | -9.74%6.89B | -5.03%4.52B | 0.44%2.18B | 18.45%10.49B |
| Operating revenue | -19.81%1.66B | -9.13%8.31B | -10.36%6.18B | -8.54%4.14B | -4.85%2.07B | -12.84%9.15B | -9.74%6.89B | -5.03%4.52B | 0.44%2.18B | 18.45%10.49B |
| Other operating revenue | ---- | -18.23%5.85M | ---- | -19.57%2.82M | ---- | 0.25%7.15M | ---- | 1.42%3.5M | ---- | 4.41%7.13M |
| Total operating cost | -12.97%1.7B | -7.60%7.99B | -8.95%5.92B | -7.55%3.9B | -4.47%1.95B | -10.28%8.65B | -7.32%6.5B | -4.60%4.22B | -0.86%2.04B | 18.17%9.64B |
| Operating cost | -13.22%1.32B | -7.66%6.2B | -10.12%4.59B | -8.67%3.01B | -4.62%1.52B | -11.10%6.72B | -9.36%5.11B | -7.34%3.3B | -2.02%1.59B | 16.84%7.56B |
| Operating tax surcharges | -39.66%6.93M | -12.94%40.98M | -1.62%31.42M | 3.14%22.66M | -0.66%11.49M | 22.47%47.07M | 18.76%31.94M | 21.43%21.97M | 4.81%11.57M | 12.59%38.44M |
| Operating expense | -12.90%178.2M | -8.01%840.78M | -4.76%651.35M | -3.70%435.95M | -3.72%204.6M | -11.84%913.95M | -0.59%683.92M | 5.68%452.7M | -4.93%212.51M | 22.62%1.04B |
| Administration expense | -0.94%104.06M | -5.67%479.94M | -1.78%328.12M | -4.02%210.98M | -3.06%105.05M | -6.00%508.78M | 2.25%334.07M | 8.26%219.81M | 13.34%108.37M | 35.92%541.26M |
| Financial expense | -20.77%63.9M | -1.03%313.43M | -1.63%236.62M | 1.30%158.76M | -3.34%80.65M | -2.14%316.68M | 1.39%240.53M | 4.11%156.72M | 16.14%83.44M | 10.96%323.59M |
| -Interest expense (Financial expense) | -16.02%68.14M | -6.34%312.86M | -5.68%237.01M | -3.03%160.87M | -3.58%81.14M | 5.07%334.04M | 7.23%251.28M | 10.89%165.9M | 16.97%84.15M | 12.77%317.92M |
| -Interest Income (Financial expense) | -88.64%-5.77M | 41.74%-13.37M | 24.32%-10.71M | 1.17%-8.27M | 15.90%-3.06M | -178.70%-22.94M | -99.29%-14.16M | -78.10%-8.37M | -104.15%-3.63M | -91.11%-8.23M |
| Research and development | -11.40%25.75M | -21.06%116.16M | -21.23%81.28M | -14.28%56.53M | -10.97%29.06M | 0.63%147.14M | 2.63%103.18M | 11.85%65.94M | 3.88%32.64M | 19.16%146.22M |
| Credit Impairment Loss | 38.11%-44.89M | 8.08%-81.71M | -66.97%-112.9M | -60.58%-86.99M | -181.38%-72.53M | 50.57%-88.9M | 43.37%-67.61M | 35.47%-54.17M | 36.16%-25.77M | -155.05%-179.86M |
| Asset Impairment Loss | 44.50%-70.18K | -4.84%-36.17M | -912.79%-3.69M | 30.52%-130.66K | ---126.45K | 15.38%-34.5M | -19.40%-364.52K | 71.91%-188.04K | ---- | -458.62%-40.77M |
| Other net revenue | 61.93%-15.58M | -75.52%37.06M | -97.60%3.8M | -109.59%-3.55M | -412.25%-40.93M | 535.61%151.42M | 3,005.65%158.45M | 532.52%36.98M | 438.60%13.11M | -144.60%-34.76M |
| Invest income | -21.03%20.67M | -52.66%109.82M | -48.59%97.82M | 3.42%70.43M | -4.73%26.18M | 69.28%232M | 97.18%190.29M | 8.29%68.1M | -6.18%27.48M | -0.60%137.05M |
| -Including: Investment income associates | -20.85%20.67M | -22.29%108.49M | -4.24%96.74M | 3.41%70.28M | -4.74%26.11M | 1.12%139.61M | 3.22%101.02M | 8.54%67.96M | -5.73%27.41M | 3.31%138.06M |
| Asset deal income | 326.59%645.78K | -2.64%11.46M | -48.36%5.54M | -60.49%2.96M | -112.11%-284.99K | 90.67%11.77M | 209.08%10.73M | 41.09%7.49M | 11.27%2.35M | 256.75%6.18M |
| Other revenue | 38.30%8.06M | 8.41%33.66M | -32.96%17.03M | -35.33%10.19M | -35.65%5.83M | -27.18%31.05M | 2.33%25.41M | 100.10%15.75M | 85.45%9.05M | 164.11%42.64M |
| Operating profit | -158.74%-49.11M | -45.26%354.06M | -52.61%258.45M | -31.78%232.22M | -45.06%83.6M | -20.77%646.8M | -12.35%545.31M | 2.74%340.38M | 40.85%152.16M | 4.96%816.37M |
| Add:Non operating Income | -46.20%908.32K | -96.35%622.46K | -35.36%8.54M | -21.92%7.43M | -76.35%1.69M | -10.47%17.06M | -0.73%13.21M | -2.05%9.51M | 464.53%7.14M | 30.36%19.06M |
| Less:Non operating expense | -25.82%527.29K | 9.96%9.14M | 54.89%6M | 44.82%2.82M | -50.91%710.81K | -47.33%8.31M | 32.21%3.87M | 26.45%1.95M | 171.66%1.45M | 31.91%15.78M |
| Total profit | -157.61%-48.73M | -47.29%345.54M | -52.95%260.99M | -31.94%236.82M | -46.42%84.57M | -20.02%655.56M | -12.31%554.64M | 2.50%347.94M | 45.14%157.85M | 5.02%819.65M |
| Less:Income tax cost | -48.35%19.14M | -26.69%156.08M | -15.67%118.88M | -2.39%84.55M | -3.76%37.05M | 29.40%212.92M | 12.67%140.98M | 34.53%86.62M | 33.32%38.5M | -9.72%164.54M |
| Net profit | -242.80%-67.86M | -57.20%189.46M | -65.65%142.1M | -41.73%152.28M | -60.18%47.52M | -32.43%442.64M | -18.47%413.66M | -5.00%261.32M | 49.41%119.35M | 9.51%655.11M |
| Net profit from continuing operation | -242.80%-67.86M | -57.20%189.46M | -65.65%142.1M | -41.73%152.28M | -60.18%47.52M | -32.43%442.64M | -18.47%413.66M | -5.00%261.32M | 49.41%119.35M | 9.51%655.11M |
| Less:Minority Profit | -94.40%1.4M | -20.76%134.18M | -29.59%91.68M | -29.39%60.97M | -34.96%24.92M | -28.66%169.34M | -35.33%130.21M | -25.26%86.34M | -0.63%38.31M | 8.90%237.36M |
| Net profit of parent company owners | -406.40%-69.26M | -79.77%55.28M | -82.21%50.42M | -47.82%91.31M | -72.11%22.6M | -34.58%273.3M | -7.38%283.45M | 9.67%174.98M | 96.09%81.04M | 9.87%417.75M |
| Earning per share | ||||||||||
| Basic earning per share | -375.00%-0.11 | -80.85%0.09 | -83.67%0.08 | -50.00%0.15 | -71.43%0.04 | -34.72%0.47 | -7.55%0.49 | 7.14%0.3 | 100.00%0.14 | 9.09%0.72 |
| Diluted earning per share | -375.00%-0.11 | -80.85%0.09 | -83.33%0.08 | -50.00%0.15 | -71.43%0.04 | -32.86%0.47 | -7.69%0.48 | 11.11%0.3 | 100.00%0.14 | 9.37%0.7 |
| Other composite income | -94.02%61.32K | 164.54%2.92M | 182.22%2.11M | 137.59%1.54M | 64.46%1.03M | -246.16%-4.52M | -112.56%-2.57M | -207.05%-4.1M | 204.93%623.63K | 21.05%3.09M |
| Other composite income of parent company owners | -93.83%56.52K | 160.61%2.56M | 183.45%1.9M | 137.95%1.38M | 67.51%915.9K | -233.00%-4.23M | -114.84%-2.27M | -210.55%-3.63M | 204.89%546.78K | 30.07%3.18M |
| Other composite income of minority owners | -95.62%4.81K | 222.87%350.52K | 172.77%214.15K | 134.81%161.85K | 42.81%109.74K | -213.10%-285.29K | -96.42%-294.3K | -182.18%-464.98K | 205.21%76.85K | -185.08%-91.12K |
| Total composite income | -239.66%-67.8M | -56.09%192.37M | -64.92%144.21M | -40.20%153.82M | -59.53%48.55M | -33.44%438.12M | -18.79%411.1M | -6.04%257.22M | 51.32%119.97M | 9.56%658.2M |
| Total composite income of parent company owners | -394.23%-69.2M | -78.50%57.85M | -81.39%52.32M | -45.91%92.69M | -71.17%23.52M | -36.08%269.07M | -7.81%281.18M | 8.18%171.35M | 99.93%81.58M | 10.00%420.93M |
| Total composite income of minority owners | -94.40%1.4M | -20.42%134.53M | -29.27%91.89M | -28.82%61.13M | -34.80%25.03M | -28.75%169.05M | -35.43%129.92M | -25.56%85.88M | -0.24%38.39M | 8.80%237.27M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Zhonghua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Asia Pacific (Group) Accounting Firm (Special General Partnership) | -- | -- | -- | Asia Pacific (Group) Accounting Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.